Pécsi Tudományegyetem, Orvostudományi és észségtudományi Centrum, Onkoterápiás Intéze

Site:	Pécsi Tudományegyetem, Orvostudományi és észségtudományi Centrum, Onkoterápiás Intéze
Address:
City:	Pécs
State:
Zip:
Country:	Hungary

Phase	Trial	Trial Status	Site Status	Drug	NCT#
3	A Phase 3 Study to Evaluate Efficacy and Safety of Masitinib in Comparison to Imatinib in Patients With Gastro-Intestinal Stromal Tumour in First Line Medical Treatment	Terminated	Active	Masitinib, (AB1010)	NCT00812240
3	A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy (StrateGIST 3)	Recruiting	Active	IDRX-42	NCT07218926
3	(VOYAGER) Study of Avapritinib vs Regorafenib in Patients With Locally Advanced Unresectable or Metastatic GIST	Active, not recruiting	Active	Avapritinib or Regorafenib	NCT03465722